Veru

VERUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$34.953 M

$2.05 -6.82%

Close of 6 Nov 2026

As of 6 Nov 2026, Veru (VERU) has a market capitalization of $35.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$16.9M

#3017 by revenue

Earnings

-$22.7M

Loss-making

Shares outstanding

17,050,320

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#354Impact BiomedicalIBO$37.6M
#355Aldeyra TherapeuticsALDX$36.7M
#356VeruVERU$35.0M
#357GridAI TechnologiesGRDX$33.9M
#358Nasus PharmaNSRX$33.8M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Veru, worth $4.84K. Grants and option exercises are excluded.

K. Gary BarnetteChief Scientific Officer$4.84K
1,800 shares at $2.69 on 13 Aug 2026 · filed 17 Aug 2026

What if Veru were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,656,091

Per share 807,849× higher

Bitcoin $1.53T

$89,608.18

Per share 43,711× higher

Apple $5.02T

$294,175.28

Per share 143,500× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Veru are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.